1. Home
  2. FLGT vs BGY Comparison

FLGT vs BGY Comparison

Compare FLGT & BGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$15.77

Market Cap

525.3M

Sector

Health Care

ML Signal

HOLD

Logo Blackrock Enhanced International Dividend Trust

BGY

Blackrock Enhanced International Dividend Trust

HOLD

Current Price

$5.80

Market Cap

515.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
BGY
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
525.3M
515.6M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FLGT
BGY
Price
$15.77
$5.80
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$28.33
N/A
AVG Volume (30 Days)
516.5K
320.8K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
7.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,730,000.00
N/A
Revenue This Year
$10.09
N/A
Revenue Next Year
$12.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.46
$5.19
52 Week High
$31.04
$6.23

Technical Indicators

Market Signals
Indicator
FLGT
BGY
Relative Strength Index (RSI) 50.60 56.12
Support Level $15.39 $5.68
Resistance Level $16.70 $5.86
Average True Range (ATR) 0.69 0.06
MACD 0.12 0.01
Stochastic Oscillator 70.33 77.27

Price Performance

Historical Comparison
FLGT
BGY

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

About BGY Blackrock Enhanced International Dividend Trust

Blackrock Enhanced International Dividend Trust is a diversified closed-end management investment company. Its primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust invests the majority of its net assets in dividend-paying equity securities issued by non-U.S. companies of any market capitalization, with a key focus on securities of large capitalization companies. It invests directly in such securities or synthetically through the use of derivatives.

Share on Social Networks: